The orexin OX 1 receptor exists predominantly as a homodimer in the basal state: Potential regulation of receptor organization by both agonist and antagonist ligands

Biochemical Journal

Volumn 439, Issue 1, 2011, Pages 171-183

  Xu, Tian Rui ^a   Ward, Richard J ^a   Pediani, John D ^a   Milligan, Graeme ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Blue native PAGE (BN PAGE); Homodimer; Orexin OX 1 receptor; Receptor organization

Indexed keywords

EPITOPE; G PROTEIN COUPLED RECEPTOR; LIGAND; OREXIN 1 RECEPTOR; YELLOW FLUORESCENT PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; CARBOXY TERMINAL SEQUENCE; HUMAN; HUMAN CELL; MIGRATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; SOLUBILIZATION;

CELL LINE; DOXYCYCLINE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; IMMUNOPRECIPITATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NEUROPEPTIDES; PROTEIN MULTIMERIZATION; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, NEUROPEPTIDE; SODIUM DODECYL SULFATE;

EID: 80052756132     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20110230     Document Type: Article

References (50)

1. Chabre, M. and le Maire, M. (2005) Monomeric G-protein-coupled receptor as a functional unit. Biochemistry 44, 9395-9403 (Pubitemid 40962038)
2. Milligan, G. (2008) A day in the life of a G protein-coupled receptor: the contribution to function of G protein-coupled receptor dimerization. Br. J. Pharmacol. 153 (Suppl. 1), S216-S229
3. Milligan, G. (2007) G protein-coupled receptor dimerisation: molecular basis and relevance to function. Biochim. Biophys. Acta 1768, 825-835
4. Pin, J. P., Kniazeff, J., Liu, J., Binet, V., Goudet, C., Rondard, P. and Prézeau, L. (2005) Allosteric functioning of dimeric class C G-protein-coupled receptors. FEBS J. 272, 2947-2955 (Pubitemid 40904683)
5. Dorsch, S., Klotz, K. N., Engelhardt, S., Lohse, M. J. and Bünemann, M. (2009) Analysis of receptor oligomerization by FRAP microscopy. Nat. Methods 6, 225-230
6. 1 muscarinic receptor dimers seen by total internal reflection fluorescence imaging of single molecules. Proc. Natl. Acad. Sci. U.S.A. 107, 2693-2698
7. Sakurai, T. (2005) Reverse pharmacology of orexin: from an orphan GPCR to integrative physiology. Regul. Pept. 126, 3-10
8. Bingham, M. J., Cai, J. and Deehan, M. R. (2006) Eating, sleeping and rewarding: orexin receptors and their antagonists. Curr. Opin. Drug Discovery Dev. 9, 551-559
9. Kroeger, D. and de Lecea, L. (2009) The hypocretins and their role in narcolepsy. CNS Neurol. Disord. Drug Targets 8, 271-280
10. Neubauer, D. N. (2010) Almorexant, a dual orexin receptor antagonist for the treatment of insomnia. Curr. Opin. Invest. Drugs 11, 101-110
11. Ellis, J., Pediani, J. D., Canals, M., Milasta, S. and Milligan, G. (2006) Orexin-1 receptor-cannabinoid CB1 receptor heterodimerization results in both ligand-dependent and -independent coordinated alterations of receptor localization and function. J. Biol. Chem. 281, 38812-38824
12. Swamy, M., Siegers, G. M., Minguet, S., Wollscheid, B. and Schamel, W. W. (2006) Blue native polyacrylamide gel electrophoresis (BN-PAGE) for the identification and analysis of multiprotein complexes. Sci. STKE 2006, pl4
13. Reisinger, V. and Eichacker, L. A. (2006) Analysis of membrane protein complexes by blue native PAGE. Proteomics 6 (Suppl. 2), 6-15
14. Alvarez-Curto, E., Pediani, J. D. and Milligan, G. (2010) Applications of fluorescence and bioluminescence resonance energy transfer to drug discovery at G protein coupled receptors. Anal. Bioanal. Chem. 398, 167-180
15. 3 muscarinic acetylcholine receptors analyzed by fluorescence resonance energy transfer (FRET) imaging and homogeneous time-resolved FRET. J. Biol. Chem. 285, 23318-23330
16. Eglen, R. M. (2002) Enzyme fragment complementation: a flexible high throughput screening assay technology. Assay Drug Dev. Technol. 1, 97-104
17. De, A., Ray, P., Loening, A. M. and Gambhir, S. S. (2009) BRET3: a red-shifted bioluminescence resonance energy transfer (BRET)-based integrated platform for imaging protein-protein interactions from single live cells and living animals. FASEB J. 23, 2702-2709
18. 1 receptors assessed via N-terminal SNAP and CLIP-tagging. Br. J. Pharmacol. 162, 1439-1452
19. Carrillo, J. J., López-Gimenez, J. F. and Milligan, G. (2004) Multiple interactions between transmembrane helices generate the oligomeric α1b-adrenoceptor. Mol. Pharmacol. 66, 1123-1137 (Pubitemid 39411053)
20. Milasta, S., Evans, N. A., Ormiston, L., Wilson, S., Lefkowitz, R. J. and Milligan, G. (2005) The sustainability of interactions between the orexin-1 receptor and β-arrestin-2 is defined by a single C-terminal cluster of hydroxy amino acids and modulates the kinetics of ERK MAPK regulation. Biochem. J. 387, 573-584
21. Bouvier, M., Heveker, N., Jockers, R., Marullo, S. and Milligan, G. (2007) BRET analysis of GPCR oligomerization: newer does not mean better. Nat. Methods 4, 3-4 (Pubitemid 46029461)
22. Tate, C. G. (2010) Practical considerations of membrane protein instability during purification and crystallisation. Methods Mol. Biol. 601, 187-203
23. Chung, I., Akita, R., Vandlen, R., Toomre, D., Schlessinger, J. and Mellman, I. (2010) Spatial control of EGF receptor activation by reversible dimerization on living cells. Nature 464, 783-787
24. Kawashima, N., Nakayama, K., Itoh, K., Itoh, T., Ishikawa, M. and Biju, V. (2010) Reversible dimerization of EGFR revealed by single-molecule fluorescence imaging using quantum dots. Chemistry 16, 1186-1192
25. Smith, N. J., Stoddart, L. A., Devine, N. M., Jenkins, L. and Milligan, G. (2009) The action and mode of binding of thiazolidinedione ligands at free fatty acid receptor 1. J. Biol. Chem. 284, 17527-17539
26. Maurel, D., Comps-Agrar, L., Brock, C., Rives, M. L., Bourrier, E., Ayoub, M. A., Bazin, H., Tinel, N., Durroux, T., Prézeau, L. et al. (2008) Cell-surface protein-protein interaction analysis with time-resolved FRET and snap-tag technologies: application to GPCR oligomerization. Nat. Methods 5, 561-567 (Pubitemid 351761765)
27. Saenz del Burgo, L. and Milligan, G. (2011) Ligand regulation of GPCR quaternary structure. In G Protein-Coupled Receptors: from Structure to Function (Giraldo, J. and Pin, J. P., eds), pp. 111-152, Royal Society of Chemistry, London
28. Gandía, J., Lluís, C., Ferré, S., Franco, R. and Ciruela, F. (2008) Light resonance energy transfer-based methods in the study of G protein-coupled receptor oligomerization. BioEssays 30, 82-89
29. Pisterzi, L. F., Jansma, D. B., Georgiou, J., Woodside, M. J., Chou, J. T., Angers, S., Raicu, V. and Wells, J. W. (2010) Oligomeric size of the M2 muscarinic receptor in live cells as determined by quantitative fluorescence resonance energy transfer. J. Biol. Chem. 285, 16723-16738
30. Doumazane, E., Scholler, P., Zwier, J. M., Trinquet, E., Rondard, P. and Pin, J. P. (2011) A new approach to analyze cell surface protein complexes reveals specific heterodimeric metabotropic glutamate receptors. FASEB J. 25, 66-77
31. 2- adrenergic receptor homo- and heterodimerization by bioluminescence resonance energy transfer. J. Biol. Chem. 277, 44925-44931
32. Fonseca, J. M. and Lambert, N. A. (2009) Instability of a class a G protein-coupled receptor oligomer interface. Mol. Pharmacol. 75, 1296-1299
33. Han, Y., Moreira, I. S., Urizar, E., Weinstein, H. and Javitch, J. A. (2009) Allosteric communication between protomers of dopamine class A GPCR dimers modulates activation. Nat. Chem. Biol. 5, 688-695
34. Kato, N. and Jones, J. (2010) The split luciferase complementation assay. Methods Mol. Biol. 655, 359-376
35. McVey, M., Ramsay, D., Kellett, E., Rees, S., Wilson, S., Pope, A. J. and Milligan, G. (2001) Monitoring receptor oligomerization using time-resolved fluorescence resonance energy transfer and bioluminescence resonance energy transfer. The human δ-opioid receptor displays constitutive oligomerization at the cell surface, which is not regulated by receptor occupancy. J. Biol. Chem. 276, 14092-14099
36. 2-adrenergic receptors: a role in trafficking and mitogen-activated protein kinase activation. Proc. Natl. Acad. Sci. U.S.A. 98, 343-348
37. 2-adrenoceptors in a model lipid bilayer. EMBO J. 28, 3315-3328
38. Whorton, M. R., Bokoch, M. P., Rasmussen, S. G., Huang, B., Zare, R. N., Kobilka, B. and Sunahara, R. K. (2007) A monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G protein. Proc. Natl. Acad. Sci. U.S.A. 104, 7682-7687
39. Rosenbaum, D. M., Rasmussen, S. G. and Kobilka, B. K. (2009) The structure and function of G-protein-coupled receptors. Nature 459, 356-363
40. Cherezov, V., Abola, E. and Stevens, R. C. (2010) Recent progress in the structure determination of GPCRs, a membrane protein family with high potential as pharmaceutical targets. Methods Mol. Biol. 654, 141-168
41. Wu, B., Chien, E. Y., Mol, C. D., Fenalti, G., Liu, W., Katritch, V., Abagyan, R., Brooun, A., Wells, P., Bi, F. C. et al. (2010) Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists. Science 330, 1066-1071
42. Marquer, C., Fruchart-Gaillard, C., Mourier, G., Grandjean, O., Girard, E., le Maire, M., Brown, S. and Servent, D. (2010) Influence of MT7 toxin on the oligomerization state of the M1 muscarinic receptor. Biol. Cell 102, 409-420
43. Robertson, N., Jazayeri, A., Errey, J., Baig, A., Hurrell, E., Zhukov, A., Langmead, C. J., Weir, M. and Marshall, F. H. (2011) The properties of thermostabilised G protein-coupled receptors (StaRs) and their use in drug discovery. Neuropharmacology 60, 36-44
44. 2a receptor. Proc. Natl. Acad. Sci. U.S.A. 105, 10744-10749
45. Ciruela, F., Vilardaga, J. P. and Fernández-Dueñas, V. (2010) Lighting up multiprotein complexes: lessons from GPCR oligomerization. Trends Biotechnol. 28, 407-415
46. Brun, M. A., Tan, K. T., Nakata, E., Hinner, M. J. and Johnsson, K. (2009) Semisynthetic fluorescent sensor proteins based on self-labeling protein tags. J. Am. Chem. Soc. 131, 5873-5884
47. 2- adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation. J. Biol. Chem. 271, 16384-16392
48. Sanchez-Laorden, B. L., Sanchez-Mas, J., Martinez-Alonso, E., Martinez-Menarguez, J. A., Garcia-Borron, J. C. and Jimenez-Cervantes, C. (2006) Dimerization of the human melanocortin 1 receptor: functional consequences and dominant-negative effects. J. Invest. Dermatol. 126, 172-181
49. Zeng, F. Y., McLean, A. J., Milligan, G., Lerner, M., Chalmers, D. T. and Behan, D. P. (2003) Ligand specific up-regulation of a Renilla reniformis luciferase-tagged, structurally unstable muscarinic M3 chimeric G protein-coupled receptor. Mol. Pharmacol. 64, 1474-1484
50. Ilien, B., Glasser, N., Clamme, J. P., Didier, P., Piemont, E., Chinnappan, R., Daval, S. B., Galzi, J. L. and Mely, Y. (2009) Pirenzepine promotes the dimerization of muscarinic M1 receptors through a three-step binding process. J. Biol. Chem. 284, 19533-19543